Final opportunity for exhibition at ENA Symposium 24
ENA 2024 is the premier drug development and translational research meeting, spotlighting preclinical and Phase I studies. It facilitates in-depth scientific discussions on the latest developments in drug targets and therapies.
Attracting an international audience of academics, scientists, and pharmaceutical leaders, the event enables exploration of new innovations in drug development, target selection, and the impact of molecular biology discoveries.
For further details, follow this link.
EORTC – European Organisation for Research and Treatment of Cancer shared on LinkedIn:
“Final opportunity for exhibition at ENA Symposium 24!
Only 2 exhibition spaces left at ENA in Barcelona. Highlight your cutting-edge drug developments and connect with key leaders in oncology. Secure your spot today!
Download the prospectus to explore the exhibition and other sponsorship opportunities.”
Source: EORTC/LinkedIn